Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
[2] Adverse GI effects reported during spironolactone therapy include nausea, vomiting, cramping, diarrhea, gastritis, abdominal pain, gastric bleeding, and ulceration.2 Adverse nervous system effects that have been reported in patients receiving spironolactone therapy include headache, dizziness, drowsiness, lethargy, ataxia, and mental confusion
Understanding Type 1 Diabetes
What the FDA announced in April 2026 directly affects the legal availability of compounded semaglutide and tirzepatide
The dual GIP/GLP-1 receptor agonism that suppresses appetite, enhances satiety, and improves insulin secretion gradually diminishes
However, anecdotal reports from patients and healthcare providers have raised questions about potential dental health changes during GLP-1 and dual GIP/GLP-1 receptor agonist therapy
US$ 27.21
US$ 20.20
US$ 22.85
US$ 28.73
US$ 29.16
US$ 21.21
US$ 26.42
US$ 25.61
US$ 28.79
US$ 25.70
US$ 22.52
US$ 23.36
